Brannin McBee, serving as Chief Development Officer at CoreWeave, Inc. (NASDAQ: CRWV), executed a series of transactions on July 6, 2026, resulting in the sale of Class A Common Stock valued at approximately $16.97 million. The shares were disposed of at prices fluctuating between $83.0884 and $87.1129 per share. At the time of the transaction, the stock was trading at $90, reflecting an increase from the $83.53 closing price recorded prior to the sale. Despite this recent movement, the equity has declined by 41% over the preceding twelve-month period.
The total volume of 197,000 shares was distributed across multiple holding structures. McBee directly sold 144,000 shares. The remaining disposition included 25,000 shares held by his spouse, 25,000 shares attributed to the Brannin J. McBee 2022 Irrevocable Trust, and 3,000 shares linked to the Canis Major 2024 Irrevocable Trust LLC. The trust structures involve specific roles and beneficiaries: McBee’s spouse acts as trustee for the 2022 Irrevocable Trust, with both the spouse and a minor child designated as beneficiaries. For the Canis Major 2024 Irrevocable Trust LLC, McBee serves as the manager. These sales were facilitated under a Rule 10b5-1 trading plan that McBee adopted on March 5, 2026.
On the same date, McBee also reported the acquisition of 197,000 shares of Class A Common Stock through the conversion of Class B Common Stock. These conversions did not require a purchase price, as the company’s Amended and Restated Certificate of Incorporation stipulates that each share of Class B Common Stock is convertible into one share of Class A Common Stock at the holder’s election or automatically upon specific conditions. The direct acquisition of 144,000 Class A shares by McBee, along with the indirect acquisitions by his spouse (25,000 shares), the Brannin J. McBee 2022 Irrevocable Trust (25,000 shares), and the Canis Major 2024 Irrevocable Trust LLC (3,000 shares), were all executed through these conversion mechanisms.
CoreWeave, which carries a valuation of $45.6 billion, has reported revenue growth of 130% over the last twelve months. This growth occurs despite the company operating with significant debt levels. Analyst sentiment, as noted by InvestingPro, suggests a 74% upside potential for CRWV. The platform also offers additional exclusive tips for CRWV and provides access to detailed Pro Research Reports for CRWV and over 1,400 other US equities.
In the broader market context, Freedom Broker recently upgraded IREN Ltd. to a Buy rating from Hold, maintaining a price target of $58.00. However, the firm lowered its revenue estimates for the quarters ending June and September 2026, indicating a more backend-weighted operational ramp for the company this year. Meanwhile, CoreWeave has received renewed analyst attention. Wolfe Research reiterated an Outperform rating with a $150.00 price target, citing increased capital expenditure estimates for fiscal 2026. Rosenblatt also maintained a Buy rating on CoreWeave with a $250 price target, referencing reports that Meta Platforms is planning to launch a cloud business. This potential Meta cloud initiative involves selling AI computing power and raw computing capacity, which could impact CoreWeave’s market position. Evercore ISI similarly maintained its Outperform rating and $150.00 price target for CoreWeave, aligning with reports about Meta’s cloud infrastructure plans. These developments have caused fluctuations in CoreWeave and Nebius Group shares, highlighting the market’s sensitivity to Meta’s strategic moves.